Paper3744129
Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties.
Holmer E and 3 others. Haemostasis, 1986. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties. Papers, record 3744129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3744129
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Coagulation | Major topic |
| Heparin | Major topic |
| Thrombosis | Major topic |
| Drug Interactions | |
| Factor X | |
| Factor Xa | |
| Hemostasis | |
| Humans | |
| Injections, Intravenous | |
| Injections, Subcutaneous | |
| Molecular Weight | |
| Monosaccharides | |
| Partial Thromboplastin Time | |
| Structure-Activity Relationship |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28365976 | New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism. | Biomol Ther (Seoul) | 2017 | https://conductscience.org/library/papers/28365976 | PubMed |
| 22315264 | Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest | 2012 | https://conductscience.org/library/papers/22315264 | PubMed |
| 10929935 | Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease. | Drugs | 2000 | https://conductscience.org/library/papers/10929935 | PubMed |
| 10767130 | Outpatient Therapy of Deep Vein Thrombosis. | J Thromb Thrombolysis | 1998 | https://conductscience.org/library/papers/10767130 | PubMed |
| 8841743 | Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders. | Drugs | 1996 | https://conductscience.org/library/papers/8841743 | PubMed |
| 2969081 | Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes. | Naunyn Schmiedebergs Arch Pharmacol | 1988 | https://conductscience.org/library/papers/2969081 | PubMed |
| 2122604 | Prophylaxis of venous thromboembolism. | World J Surg | 1990 | https://conductscience.org/library/papers/2122604 | PubMed |
| 1662323 | [Low molecular weight heparin: how does it modify lipid metabolism in chronic hemodialysis patients?]. | Klin Wochenschr | 1991 | https://conductscience.org/library/papers/1662323 | PubMed |
| 1505142 | Heparin pharmacokinetics and pharmacodynamics. | Clin Pharmacokinet | 1992 | https://conductscience.org/library/papers/1505142 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3744129
GET https://conductscience.org/api/papers/v1/3744129/authors